Literature DB >> 3385423

Lack of correlation between DST results and urinary MHPG in depressed inpatients.

H Lôo1, M F Poirier, T Dennis, C Benkelfat, J M Vanelle, C Gay, A Galinowski, S Askienazy, B Scatton.   

Abstract

Abnormalities of noradrenaline metabolism and of the activity of hypothalamic-pituitary adrenal axis (HPA) have been reported in depression. To study the possible relationship between these 2 parameters, urinary excretion of 3-methoxy-4-hydroxy-phenylethyleneglycol (MHPG) and Dexamethasone Suppression Test (DST) were analyzed in 58 depressed patients. A positive correlation was found between the age of depressed patients and 24-h urinary excretion of MHPG. Twenty-two patients (38%) were DST non suppressors. Pre-DST plasma cortisol levels were significantly higher in non suppressors than suppressors. No difference was found however between urinary MHPG levels in suppressors and non suppressors. There was no correlation between pre-DST plasma cortisol and levels of urinary excretion of MHPG. These results do not support the hypothesis of a relationship between these 2 parameters. However, when depressed patients were separated into two groups according to urinary excretion of MHPG ("high MHPG" and "low MHPG"), the "high MHPG" group included significantly more non suppressors then the "low MHPG" one. This result is not sufficient to demonstrate of link between HPA system activity and central noradrenaline metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385423     DOI: 10.1007/bf01250235

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  32 in total

Review 1.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

Review 2.  Biogenic amine hypotheses of affective disorders.

Authors:  D L Garver; J M Davis
Journal:  Life Sci       Date:  1979-01-29       Impact factor: 5.037

3.  Unexpected neuroendocrine-transmitter relationships [proceedings].

Authors:  P E Stokes; A Frazer; R Casper
Journal:  Psychopharmacol Bull       Date:  1981-01

4.  Noradrenergic function and the cortisol response to dexamethasone in depression.

Authors:  A L Rubin; L H Price; D S Charney; G R Heninger
Journal:  Psychiatry Res       Date:  1985-05       Impact factor: 3.222

Review 5.  Neuroendocrine dysfunction in depressive illness.

Authors:  E J Sachar
Journal:  Annu Rev Med       Date:  1976       Impact factor: 13.739

6.  The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry.

Authors:  M Berger; K M Pirke; P Doerr; J C Krieg; D von Zerssen
Journal:  Br J Psychiatry       Date:  1984-10       Impact factor: 9.319

7.  Neuroendocrine and neurochemical measurements in depression.

Authors:  K L Davis; L E Hollister; A A Mathé; B M Davis; A B Rothpearl; K F Faull; J Y Hsieh; J D Barchas; P A Berger
Journal:  Am J Psychiatry       Date:  1981-12       Impact factor: 18.112

Review 8.  Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness.

Authors:  S A Checkley
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

9.  Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification.

Authors:  M A Schlesser; G Winokur; B M Sherman
Journal:  Arch Gen Psychiatry       Date:  1980-07

10.  Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patients.

Authors:  H Lôo; T Dennis; J M Vanelle; L Rouquier; M F Poirier-Littré; M Garreau; C Benkelfat; D Sechter; B Scatton
Journal:  Biol Psychiatry       Date:  1986-08       Impact factor: 13.382

View more
  2 in total

1.  Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.

Authors:  M Maes; B Minner; E Suy; C Vandervorst; J Raus
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.

Authors:  A V Araya; P Rojas; R Fritsch; R Rojas; L Herrera; G Rojas; H Gatica; H Silva; J L Fiedler
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.